Did you know that the U.S. NASH Action Plan is the first and only national action plan created to address the growing epidemic of NASH? In 2021, GLI NASH Council partners...
As the world continues to gain a better understanding of COVID-19 and ever present and new variants, Global Liver Institute wants to ensure that we are here to continue to guide, educate, and...
Global Liver Institute and partners bring together expert speaker panels, patient/provider materials in 16 languages and community screening events (Washington, DC – May 9, 2022) – In exactly...
(Washington, D.C., May 3, 2022) – Global Liver Institute (GLI), a premier patient-led liver health nonprofit operating globally, is deeply concerned by the draft opinion published...
(Washington, D.C., April 29, 2022) – As leaders in the liver cancer community, Global Liver Institute and their Liver Cancers team expresses our gratitude and recognizes Dr. Ned Sharpless and...
Welcome to the very first edition of Pediatric & Rare Liver Diseases News! As we expand our offerings for and about this community, Global Liver Institute is also committed to keeping...
Today, April 6, the members of the Liver Action Network (LAN) pledge our collective support for Living Donor Day to honor the donors, recipients, families and caregivers, and clinical teams that...
Transforming Global Consciousness of Liver Health through Education and Advocacy (Washington, D.C., March 30, 2022) – Global Liver Institute (GLI), a patient-led liver health nonprofit...
New Season, New Format: Striving to meet the needs of the expanding liver health- interested community for timely information on must-know events and news specific to our Council communities...
Interested in learning more? Check out what GLI’s President and CEO Donna Cryer, JD has to say on Season 3, Episode 12 of Surfing the NASH Tsunami here. Nonalcoholic steatohepatitis (NASH) has a...
Recent News
Advancing Screening, Science & AdvocacyA Note from the Director, Dr. Sharon H. Jaycox Reflections on the American Diabetes Association (ADA) Scientific Sessions I recently had the privilege of attending the ADA Scientific Sessions in Chicago. One of the key themes...
GLI Supports the Bipartisan Reintroduction of the Treat and Reduce Obesity Act(Washington, D.C., July 8, 2025) – Global Liver Institute (GLI) applauds the reintroduction of the bipartisan Treat and Reduce Obesity Act (TROA) in the U.S. House of Representatives last...
Treatment Strategies and Advancements in TestingGlobal Liver Institute brings you key updates on emerging treatment strategies and advocacy efforts from global leaders like the World Hepatitis Alliance. In this issue, we offer new resources, a short quiz to see if...
Global Research and Patient Priorities Emphasizing the Importance of Using Patient-Reported Data at the DIA 2025 Conference, Washington, D.C. Kristin Hatcher, Director of GLI’s Pediatric and Rare Liver Disease Program, joined U.S. and global...
Culturally Relevant Tools to Increase Hepatitis B Screening in Asian American CommunitiesInfection with hepatitis B poses a serious risk to the health of many Americans – especially in certain groups with high risk, including Asian Americans and Asian-American...
